2019 annual financial data
Akebia Therapeutics 2019 Net margin
Direct answer
Net margin was -83.48%.
Operating income was -286,288,000 USD and net income was -279,659,000 USD.
Operating cash flow was -257,441,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 335,001,000 USD
- Operating income
- -286,288,000 USD
- Net income
- -279,659,000 USD
- Operating cash flow
- -257,441,000 USD